相关实验视频

Updated: May 28, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

瘤透性淋巴细胞,CAR和T细胞受体修饰的T细胞在固体癌症瘤学中

Hakim Echchannaoui^1,2,3, Kevin Jan Legscha^1,2, Matthias Theobald^1,2,3

¹Department of Hematology and Medical Oncology, University Cancer Center (UCT), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany.

Oncology research and treatment

|February 12, 2025

概括

采用细胞疗法 (ACT) 对固体癌症有希望,但面临着挑战. 下一代策略旨在提高T细胞疗法的疗效,安全性和患者获取.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

采用细胞疗法 (ACT) 增强T细胞抗瘤反应.
目前的ACT,包括CAR-T细胞,在固体癌症中存在局限性.
在固体瘤中,只有很少的患者才能获得持久的反应.

研究的目的:

审查T细胞治疗固体癌症的进展和局限性.
讨论下一代ACT战略.
突出新兴技术以提高效率和安全性.

主要方法:

对实体癌症的ACT当前文献的综述.
讨论下一代ACT的新策略.
分析新兴技术和组合疗法.

主要成果:

在耐火固体癌症中,ACT已经显示出适度的临床反应.
在少数患者中,持久反应仍然有限.
正在制定下一代ACT战略,以克服这些局限性.

结论:

在ACT的进步正在推动固体癌症的免疫疗法向前发展.
下一代疗法旨在提高疗效和安全性.
更广泛的患者获得有效的ACT是关键目标.

关键词:

细胞免疫疗法细胞免疫疗法化学抗原受体的化学抗原受体固体癌症是一种固体癌症.这种T细胞受体是T细胞受体.瘤透的淋巴细胞透到瘤中

更多相关视频

A Spheroid Killing Assay by CAR T Cells

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.